title: Ortho markets first FDA-approved triphasic pill.
mesh_terms: D000569:Americas; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D019049:Developed Countries; D003906:Developing Countries; D004467:Economics; D005193:Family Planning Services; D008389:Marketing of Health Services; D009656:North America; D019064:Product Packaging; D012106:Research; D013672:Technology; D014481:United States
chemical_list: D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined
keywords: Americas; Clinical Research; Contraception; Contraception Failure; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Methods; Contraceptive Methods--administraction and dosage; Developed Countries; Developing Countries; Economic Factors; Family Planning; Macroeconomic Factors; Marketing; North America; Northern America; Oral Contraceptives; Oral Contraceptives, Combined--administraction and dosage; Oral Contraceptives, Phasic--administraction and dosage; Packaging; Pearl's Formula; Research And Development; Research Methodology; Technology; United States